Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differences in 30-day complications and 1-year mortality by sex in patients with a first STEMI managed by the Codi IAM network between 2010 and 2016.
Tizón-Marcos H, Vaquerizo B, Marrugat J, Ariza A, Carrillo X, Muñoz JF, Cárdenas M, García-Picart J, Rojas SG, Tomás-Querol C, Massotti M, Lidón RM, Jiménez J, Martí-Almor J, Farré N, Pérez-Fernández S, Curós A, Mauri Ferré J. Tizón-Marcos H, et al. Among authors: massotti m. Rev Esp Cardiol (Engl Ed). 2021 Aug;74(8):674-681. doi: 10.1016/j.rec.2020.06.002. Epub 2020 Jul 11. Rev Esp Cardiol (Engl Ed). 2021. PMID: 32660910 English, Spanish.
Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial. An intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stent.
Otaegui Irurueta I, González Sucarrats S, Barrón Molina JL, Pérez de Prado A, Massotti M, Carmona Ramírez MÁ, Martí G, Bellera N, Serra B, Serra V, Domingo E, López-Benito M, Sabaté M, Ferreira González I, García Del Blanco B. Otaegui Irurueta I, et al. Among authors: massotti m. Int J Cardiol. 2022 Aug 1;360:13-20. doi: 10.1016/j.ijcard.2022.04.043. Epub 2022 Apr 25. Int J Cardiol. 2022. PMID: 35472561 Clinical Trial.
Intrapatient Randomization to Study Strut Coverage in Polymer-Free Versus Biodegradable-Polymer Sirolimus-Eluting Stent Implantations.
Otaegui I, Pérez de Prado A, Massotti M, López-Benito M, Sabaté M, Martí G, Bellera N, Serra B, García Del Blanco B, Ferreira González I. Otaegui I, et al. Among authors: massotti m. JACC Cardiovasc Interv. 2020 Apr 13;13(7):899-900. doi: 10.1016/j.jcin.2019.11.020. JACC Cardiovasc Interv. 2020. PMID: 32273102 Free article. Clinical Trial. No abstract available.
Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Catalonia (Spain).
Ribera A, Ferreira-Gonzalez I, Marsal JR, Oristrell G, Faixedas MT, Rosas A, Tizón-Marcos H, Rojas S, Labata C, Cardenas M, Homs S, Tomas-Querol C, Garcia-Picart J, Gomez-Hospital JA, Pijoan JI, Masotti M, Mauri J, Garcia Dorado D; VESA Study and Codi IAM Investigators. Ribera A, et al. BMJ Open. 2019 Jul 23;9(7):e028114. doi: 10.1136/bmjopen-2018-028114. BMJ Open. 2019. PMID: 31340964 Free PMC article.
Early ST elevation myocardial infarction in non-capable percutaneous coronary intervention centres: in situ fibrinolysis vs. percutaneous coronary intervention transfer.
Carrillo X, Fernandez-Nofrerias E, Rodriguez-Leor O, Oliveras T, Serra J, Mauri J, Curos A, Rueda F, García-García C, Tresserras R, Rosas A, Faixedas MT, Bayes-Genis A; Codi IAM Investigators. Carrillo X, et al. Eur Heart J. 2016 Apr 1;37(13):1034-40. doi: 10.1093/eurheartj/ehv619. Epub 2015 Nov 18. Eur Heart J. 2016. PMID: 26586783
Report from the Italian Ministerial Committee regarding the diagnosis, care and assistance of patients with ALS.
Bendotti C, Chiò A, Congiu ME, De Sanctis Lucentini E, Ferlito E, Garaci E, Massotti M, Mazzini L, Mora G, Oleari F, Robberecht W, Silani V, Taioli E. Bendotti C, et al. Among authors: massotti m. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Mar;6(1):5-7. doi: 10.1080/14660820510027044. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005. PMID: 16036420 No abstract available.
Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity.
Popoli P, Pintor A, Tebano MT, Frank C, Pepponi R, Nazzicone V, Grieco R, Pèzzola A, Reggio R, Minghetti L, De Berardinis MA, Martire A, Potenza RL, Domenici MR, Massotti M. Popoli P, et al. Among authors: massotti m. J Neurochem. 2004 Jun;89(6):1479-89. doi: 10.1111/j.1471-4159.2004.02448.x. J Neurochem. 2004. PMID: 15189351 Free article.
Metabotropic glutamate receptor 5 (mGluR5)-mediated phosphoinositide hydrolysis and NMDA-potentiating effects are blunted in the striatum of aged rats: a possible additional mechanism in striatal senescence.
Domenici MR, Pintor A, Potenza RL, Gaudi S, Grò MC, Passarelli F, Reggio R, Galluzzo M, Massotti M, Popoli P. Domenici MR, et al. Among authors: massotti m. Eur J Neurosci. 2003 May;17(10):2047-55. doi: 10.1046/j.1460-9568.2003.02649.x. Eur J Neurosci. 2003. PMID: 12786971
59 results